One notable and relevant example for CD is the transgenic model developed by Liu and collaborators (2011) overexpressing the pituitary tumor-transforming gene (PTTG/securin), a gene often dysregulated in pituitary tumors, in pomc-positive pituitary lineages [103]. Here, PTTG1 is linked to neoplasm.